M. Youngman

发表

N-Acylated α-(3-pyridylmethyl)-β-aminotetralin antagonists of the human neuropeptide Y Y5 receptor

Sandy J. Wilson, T. Lovenberg, D. Nepomuceno, 2000 .

alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonists.

T. Lovenberg, S. Wilson, A. Reitz, 2000, Journal of medicinal chemistry.

N-acylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagoinists of the human neuropeptide Y Y5 receptor.

T. Lovenberg, S. Wilson, D. Nepomuceno, 2000, Bioorganic & medicinal chemistry letters.

N-(sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptor.

T. Lovenberg, S. Wilson, D. Nepomuceno, 2000, Bioorganic & medicinal chemistry letters.

Mannich reactions of resin-bound substrates: 2. A versatile three-component solid-phase organic synthesis methodology

S. Dax, J. Mcnally, M. Youngman, 1998 .

Synthesis and structure--activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonists.

Sui-Po Zhang, R. Colburn, D. Stone, 2003, Bioorganic & medicinal chemistry letters.

Novel non-peptidic neuropeptide Y Y2 receptor antagonists.

P. Bonaventure, J. A. Jablonowski, W. Chai, 2004, Bioorganic & medicinal chemistry letters.

Design and synthesis of novel pyrrolidine-containing bradykinin antagonists.

C. Reynolds, Sui-Po Zhang, D. Hlasta, 2003, Bioorganic & medicinal chemistry letters.

Solid‐Phase Mannich Reactions of a Resin‐Immobilized Alkyne

S. Dax, M. Youngman, 2001 .

Solid-phase Mannich condensation of amines, aldehydes, and alkynes: investigation of diverse aldehyde inputs.

S. Dax, M. Youngman, 2001, Journal of combinatorial chemistry.

Multi-component methodologies in solid-phase organic synthesis.

S L Dax, J J McNally, M A Youngman, 1999, Current medicinal chemistry.

Heteroaryl β-tetralin ureas as novel antagonists of human TRPV1

A. Dubin, M. McDonnell, Sui-Po Zhang, 2007 .

MANNICH REACTIONS OF A RESIN-BOUND TERMINAL ALKYNE

S. Dax, M. Youngman, 1997 .

Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep).

Yu-Kai Lee, Sharmila Patel, W. Cheung, 2015, Journal of medicinal chemistry.

Enantioselective Diels-Alder reactions: room temperature bis(oxazoline)-zinc, -magnesium, and -copper triflate catalysts

D. Quincy, E. Lawson, J. M. Takacs, 1997 .

Multi-Component Methodologies in Solid-Phase Organic Synthesis

S. Dax, J. Mcnally, M. Youngman, 1999, Current Medicinal Chemistry.

Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions.

D. Holt, R. Rivero, A. Shu, 2020, Journal of medicinal chemistry.

The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.

M. Brandt, T. Hutchinson, C. M. Flores, 2012, Bioorganic & medicinal chemistry letters.

α-Substituted N-(Sulfonamido)alkyl-β-aminotetralins: Potent and Selective Neuropeptide Y Y5 Receptor Antagonists

Allen B. Reitz, Sandy J. Wilson, T. Lovenberg, 2000 .

The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure.

Paul N. Mortenson, D. J. Price, L. Shewchuk, 2020, Bioorganic & medicinal chemistry.

N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.

A. Dubin, Sui-Po Zhang, N. Nasser, 2004, Bioorganic & medicinal chemistry letters.

N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1).

A. Dubin, M. McDonnell, Sui-Po Zhang, 2008, Bioorganic & medicinal chemistry letters.

N‐Isoquinolin‐5‐yl‐N′‐aralkyl‐urea and ‐amide Antagonists of Human Vanilloid Receptor 1.

A. Dubin, Sui-Po Zhang, N. Nasser, 2004 .

Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.

D. Ludovici, M. Brandt, T. Hutchinson, 2013, Bioorganic & medicinal chemistry letters.